AcelRx Pharmaceuticals announced a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock for stock deal at an exchange ratio of 0.6303 shares of AcelRx ...
AcelRx Pharmaceuticals, Inc today announced that that Vincent J. Angotti, Chief Executive Officer, will be presenting at the 30th Annual ROTH Conference, the 38th Annual Cowen Health Care Conference and the 28th Annual Oppenheimer Healthcare Conference.